Loading...
Obinutuzumab: A FDA approved monoclonal antibody in the treatment of untreated chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is an adult lymphoid malignancy with a variable clinical course. There is considerable interest in the identification of new treatments, as most current approaches are not curative. While most patients respond to initial chemotherapy, relapsed disease is often resi...
Na minha lista:
| Udgivet i: | Int J Appl Basic Med Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4318103/ https://ncbi.nlm.nih.gov/pubmed/25664270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-516X.149245 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|